PD-1 Class Shows Promise in Multiple Cancers

News

Two agents representing a new class of oncology treatment entered the market at the end of 2014. With fast-tracked approvals in the fourth quarter, Merck’s Keytruda and BMS’s Opdivo were both approved for the treatment of advanced melanoma with a specific gene mutation (BRAF V600) in patients who have failed on other treatments. Both drugs…

Read more

Payer Dynamics in Hep C Market Begin to Level Out

News

With the successful launch of the only monotherapy option in the HCV space, Gilead continues to have a strong hold on the Hepatitis C market. In contrast, AbbVie’s recent entry into the market with Viekira Pak has been slow out of the gate. According to Synoma Health Analytics’ Integrated Dataverse (IDV)™, Harvoni, launched this fall,…

Read more

Electronic Prescribing Takes the Lead

News

Synoma Health Analytics’ Integrated Dataverse (IDV)™ shows that by mid-2013, more than half of all prescriptions in the U.S. were presented via electronic prescribing. Written prescriptions –- a piece of paper handed over by the physician during the office visit –- continue to be the next most predominant type. While other types of prescriptions have…

Read more

New Analysis Shows Impact of High Deductible Plans on Healthcare Utilization

News

A new study released by Synoma Health Analytics shows lower utilization of prescription medications among participants in high-deductible health plans (HDHP) and higher overall out-of-pocket costs. The study looked specifically at utilization behaviors of multiple myeloma patients. An analysis of de-identified longitudinal patient claims from Symphony’s Integrated Dataverse (IDV)™ was conducted, looking at patients with…

Read more

Harvoni Launch Outpacing Sovaldi

News

Despite a higher price point and aggressive access controls, Gilead’s second entry into the Hepatitis C market has been exceeding the highly successful launch trends of their prior entry. According to Synoma Health Analytics’ Integrated Dataverse (IDV)™, Harvoni, launched this fall, reached 5,000 average weekly filled prescriptions in week 8, while Sovaldi, launched at the…

Read more

Filter By Category

For media inquiries and story support requests, please contact

Heather Varela Director Marketing Communications 602-381-9880 Request Press Kit